Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Posthuma EFMW"'
Autor:
Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. m.brink@iknl.nl., Minnema MC; Department of Hematology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Posthuma EFMW; Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands., Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Roeloffzen WWH; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands., van Rooijen CR; Department of Hematology, Medical Center Twente, Enschede, The Netherlands., Geerts PAF; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., Zweegman S; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 Mar 15; Vol. 12 (3), pp. 41. Date of Electronic Publication: 2022 Mar 15.
Autor:
Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. m.brink@iknl.nl., Groen K; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Minnema MC; Department of Hematology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands., Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Ypma PF; Department of Hematology, Haga Teaching Hospital, The Hague, The Netherlands., de Waal E; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Posthuma EFMW; Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands., Zweegman S; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van de Donk NWCJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2021 Nov 11; Vol. 11 (11), pp. 178. Date of Electronic Publication: 2021 Nov 11.